Table 2.
Patient group | MSI subtypes | ||
---|---|---|---|
MSS | MSI-L | MSI-H | |
Tumor tissue (n = 30) | 7 (23.3%)* | 15 (50%) | 8 (26.7%)** |
IM tissue (n = 75) | 39 (52%)* | 29 (38.7%) | 7 (9.3%)** |
Cancer patients (N = 30) | 14 (46.7%) | 12 (40%) | 4 (13.3%) |
Noncancer patients (N = 45) | 25 (55.6%) | 17 (37.8%) | 3 (6.7%) |
*P = 0.009; **P = 0.03.